Ascendis Pharma A (ASND) Receivables - Other (2012 - 2026)
Ascendis Pharma A (ASND) reported Receivables - Other of $30.79 million for the quarter ended Jun 30, 2026, up 515.3% from $5 million a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Receivables - Other (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A posted Receivables - Other of $12.28 million, up 186.2% from the prior year.
- Receivables - Other has increased for three consecutive years, with a five-year compound annual growth rate of 4.3% (years ended Dec 2020 to Dec 2025).
- By year, Receivables - Other came in at $4.29 million in the year ended Dec 31, 2024 (+1.5%), $4.23 million in the year ended Dec 31, 2023 (+109.0%), $2.02 million in the year ended Dec 31, 2022 (-85.6%) and $14.04 million in the year ended Dec 31, 2021 (+41.4%).
- Five-year quarterly Receivables - Other spans a low of $1.91 million in the quarter ended Sep 30, 2022 and a high of $32.04 million in the quarter ended Mar 31, 2026.
- Year over year, Receivables - Other has now increased in each of the last three quarters, with growth averaging 225.1% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was the quarter ended Mar 31, 2026 (growth of 576.7%); the low point was the quarter ended Sep 30, 2022 (a decline of 92.0%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $32.04 million (quarter ended Mar 31, 2026), $12.65 million (quarter ended Dec 31, 2025) and $8.15 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.92 Mn |
| Mar 31, 2026 | 31.36 Mn |
| Dec 31, 2025 | 10.95 Mn |
| Sep 30, 2025 | 8.18 Mn |
| Jun 30, 2025 | 5.18 Mn |
| Mar 31, 2025 | 4.87 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 10.09 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 2.26 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 9.23 Mn |
| Dec 31, 2022 | 4.14 Mn |
| Sep 30, 2022 | 3.69 Mn |
| Jun 30, 2022 | 3.46 Mn |
| Mar 31, 2022 | 9.03 Mn |
| Dec 31, 2021 | 13.90 Mn |
| Sep 30, 2021 | 23.50 Mn |
API Access
Ascendis Pharma A Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();